Related content

Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case–control study and meta-analysis

By Deng Zai-Chun   Cao Chao   Yu Yi-Ming   Ma Hong-Ying   Ye Meng  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 1805-1811

Springer Publishing Company

Access to resources Recommend Favorite

Vascular endothelial growth factor polymorphisms as effect modifiers of oral squamous cell carcinoma risk: A systematic review and meta-analysis

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 347-352

Science Publishers

Access to resources Recommend Favorite

Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis

By Jiang Zheng  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 203-212

Springer Publishing Company

Access to resources Recommend Favorite

Vascular endothelial growth factor +936C/T polymorphism and gastric cancer risk: A meta-analysis

By            

Experimental and Therapeutic Medicine, Vol. 2, Iss. 5, 2011-01 ,pp. : 931-936

Spandidos Publications

Access to resources Recommend Favorite

Three Vascular Endothelial Growth Factor Polymorphisms (-460C>T, -2578C>A, 1612G>A) with Cancer Risk: A Meta-Analysis Based on 30 Case-Control Studies

By Hong Ting-Ting   Cai Dong-Yan   Wu Xiao-Hong   Hua Dong  

Cancer Investigation, Vol. 29, Iss. 7, 2011-07 ,pp. : 472-477

Informa Healthcare

Access to resources Recommend Favorite